Table 2.
The miRNA of MSC-EVs is involved in angiogenesis, immunomodulation, and antifibrosis.
| Properties of MSC-EVs | Classification of MSC-EVs | MiRNA | References | |
|---|---|---|---|---|
| 1 | Angiogenesis | Porcine ASC-EVs | MicroRNA-148 | (88, 90) |
| Human MSC-Exos | MiRNA-21-5p | (96) | ||
| ASC-MVs | MiRNA-31 | (79) | ||
| MSC-Exos | MiRNA-125a | (100) | ||
| ASC-Exos | MicroRNA-181b | (101) | ||
| 2 | Immunomodulation | MSC-Exos | MiRNA-23a-3p | (102) |
| BM-MSC-Exos | MiRNA-146a-5p | (103) | ||
| MSC-Exos | MiRNA-125a and miRNA-125b | (104) | ||
| ASC-Exos | MiRNA-10a | (105) | ||
| MSC-Exos | MiRNA-182 | (106) | ||
| BM-MSC-Exos | MiRNA-34c-5p | (107) | ||
| 3 | Antifibrosis | MSC-EVs | MiRNA-29a-3p | (69) |
| MSC-EVs | MicroRNA-29b-3p | (108) | ||
| BM-MSC-EVs | MicroRNA-186 | (109) | ||
| MSC-Exos | MiRNA-196b-5p | (67) |